Company intelligence / Profile preview
NeoTrail Therapeutics
San Francisco, California, United States
- Ownership
- Private
- Development stage
- Other
01
Overview
NeoTrail Therapeutics is a pre-clinical stage biotechnology company focused on developing next-generation adoptive cell therapies for solid tumors. The company's proprietary platform focuses on metabolic reprogramming of T cells to enhance their fitness, persistence, and anti-tumor activity within the immunosuppressive tumor microenvironment. By optimizing the metabolic state of engineered cells, NeoTrail aims to overcome the traditional limitations of cell therapy in treating solid cancers. Headquartered in the San Francisco Bay Area, the company is backed by prominent life science venture capital firms.
- Therapeutic areas
- Oncology
- Modalities
- Cell therapyT cell receptor engineered T cell therapyAdoptive cell therapy
- Industry
- Biotech
02
Drug pipeline
2 assets1 more asset in the full pipeline.
Request access →Beyond the preview
Go deeper on NeoTrail Therapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on NeoTrail Therapeutics.